Loading company details...
Beta
Latest Form 4 (Sep 3, 2026): Mark Ragosa (CHIEF FINANCIAL OFFICER): Exercise/Conversion of 2,694 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 3, 2026 | Mark Ragosa, CHIEF FINANCIAL OFFICER | Exercise/Conversion | 2,694 | n/a |
| Sep 3, 2026 | Sanj K. Patel, CHAIRMAN & CEO | Exercise/Conversion | 9,991 | n/a |
| Sep 3, 2026 | Sanj K. Patel, CHAIRMAN & CEO | Exercise/Conversion | 9,991 | n/a |
| Sep 3, 2026 | John F. Paolini, CHIEF MEDICAL OFFICER | Exercise/Conversion | 2,497 | n/a |
| Sep 3, 2026 | Ross Moat, CHIEF OPERATING OFFICER | Exercise/Conversion | 2,477 | n/a |
| Sep 3, 2026 | Michael R. Megna, CHIEF ACCOUNTING OFFICER | Grant/Award | 279 | $9.3K |
| Aug 21, 2026 | Barry D. Quart | Gift | 2,600 | n/a |
| Aug 4, 2026 | Richard S. Levy | Exercise/Conversion | 403 | n/a |
| Jul 31, 2026 | G. Bradley Cole | Sale | 3,673 | $299.1K |
| Jul 6, 2026 | Dhiraj H. Malkani, CHIEF STRATEGY OFFICER | Grant/Award | 82,600 | n/a |